Soo Bang is the Sr. Vice President of K36 Therapeutics, where she leads Strategy and Operations for a private biotech company developing epigenetic small molecules for multiple myeloma and other solid tumors. Prior to her current role, Soo founded Integration Alliance Partners, a private consulting company that shapes, grows and builds biotech companies to bring innovative therapies to the market.
Before her consulting role, Soo led the largest biotech and pharma integration as VP, Enterprise Integration Management at BMS. She led the $74 billion Celgene integration across key milestones, strategic planning of markets, and integration activities. At Celgene, Soo built an 8-year career with a range of growing responsibilities, most recently as VP of Business Strategy, Integration & Planning for the Global Pharmaceutical Development & Operations, where she had overall responsibility for project management, operational excellence, EHS, technical commercialization, and alliance management teams.
Soo spent four years as the Executive Director, Business Development & Global Alliances, managing alliance relationships across Hem/Onc, I&I, and Early Development, and was the BD and alliance lead for numerous collaborations with clinical programs in biologics and small molecules. She also played a key role in the acquisition of two late-stage oncology and hematology assets and program out licensing. Prior to the BD role, she was the Global Head of Clinical Site Contracts, leading a global team responsible for study start-up activities.
Before Celgene, Soo was the Global Investigator Lead at Pfizer, responsible for contract and outsourcing across all BUs, and medical affairs. She also held various leadership positions at Medstar Research Institute, NYC Health & Hospitals Corp, Director of Clinical Trials at NYU Medical Center, and Winthrop University. She also served as an industry lead for the “Advancing the use of Central IRBs” for the Clinical Trials Transformation Initiative, a private-public initiative with the FDA.
Soo received her B.A. and M.S. from George Washington University and completed her administrative fellowship at Johns Hopkins Health System. She is a certified Alliance Management Professional and has a green belt in Lean Six Sigma. Soo has been a passionate partner with several Patient Advocacy groups in brain tumor research groups, LLS, and PanCAN. She is also actively involved in the career development of others by leading mentorship programs within Celgene, Society of Neuro-Oncology Women & Diversity Committee, Women Leaders in Oncology at ASCO, and the Healthcare Businesswomen’s Association.
Soo Bang, MHSA, CA-AM